🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the prevalence of transthyretin c...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2023-07-14
Trial ID
NCT04899180
Treatments Being Tested
Amyloid deposition in the heart is called cardiac amyloidosis (CA); 95% is ...
Status
Recruiting
Location
Far Eastern Memorial Hospital
Start Date
2022-11-01
Trial ID
NCT05593679
Treatments Being Tested
To estimate the prevalence of transthyretin cardiac amyloidosis (TTR-CA) am...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2017-12-01
Trial ID
NCT03414632
Treatments Being Tested
Recent studies have shown that transthyretin amyloidosis (ATTR) can sometim...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2020-10-02
Trial ID
NCT05577819
Treatments Being Tested
Cardiac amyloidosis is characterized by deposition of misfolded protein in ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07529860
Treatments Being Tested
1. Patients will undergo clinical and laboratory assessment, as well as ima...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11-01
Trial ID
NCT04146415
Treatments Being Tested
This study will investigate 99mTc-p5+14, an amyloid-reactive synthetic pept...
Status
Recruiting
Location
University of Tennessee Graduate School of Medicine
Start Date
2023-09-18
Trial ID
NCT05951816
Treatments Being Tested
Our ultimate goal is to design a multi-center randomized trial to test the ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-03
Trial ID
NCT04363294
Treatments Being Tested
In this study, the investigators recruited a cohort of elderly Black and Hi...
Status
Completed
Location
Yale University/Yale New Haven Medical Center
Start Date
2019-05-15
Trial ID
NCT03812172
Treatments Being Tested